Contineum Therapeutics
CTNM
#7245
Rank
NZ$1.08 B
Marketcap
NZ$28.80
Share price
0.41%
Change (1 day)
62.39%
Change (1 year)

Earnings for Contineum Therapeutics (CTNM)

Earnings in 2026 (TTM): -NZ$99.69 Million

According to Contineum Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.11 Billion a decrease over its 2024 earnings that were of -NZ$71.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Contineum Therapeutics from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$99.69 Million-1.21%
2025 -NZ$0.11 Billion41.93%
2024 -NZ$71.1 Million-282.38%
2023 NZ$38.97 M